亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢康寶泰精細化工有限公司武昌一部  

醫藥中間體,維生素,植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:付經理
  • 電話:027-87738695
  • 郵件:664219562@qq.com
  • 傳真:027-87738652
  • QQ:664219562
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 2-***并咪唑
2-***并咪唑
單價 1.00 / 千克對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 10000千克起訂1千克
品牌 康寶泰
型號 583-39-1
規格 25
過期 長期有效
更新 2013-11-28 10:51
 
詳細信息
中文名稱: 2-***并咪唑
中文同義詞: 1,3-二氫-2H-苯并咪唑-2-硫酮;苯并二氮唑-2-硫酚;防老劑MB;鄰苯攪硫脲;麻瘋寧;巰苯咪唑;橡膠防老劑MB;2-***并咪唑
英文名稱: 2-Mercaptobenzimidazole
英文同義詞: 1,3-dihydro-2h-benzimidazole-2-thion;1,3-Dihydro-2H-benzimidazole-2-thione;1,3-Dihydro-benzoimidazole-2-thione;1H-Benzimidazol-2-yl hydrosulfide;2,3-Dihydro-1H-benzimidazole-2-thiol;2-Benzimidazolethione;2-Benzimidazolinethione;2-benzimidazolinthion
CAS號: 583-39-1
分子式: C7H6N2S
分子量: 150.2
EINECS號: 209-502-6
相關類別: 電鍍化學品;化工助劑;苯并雜環;Rubber Chemicals;BENZIMIDAZOLE;Industrial/Fine Chemicals;PHARMACEUTICAL INTERMEDIATES;Organics;Imidazole;Imidazoles;Intermediates of Rabeprazole;Aromatics;Heterocycles;Miscellaneous Reagents;Sulfur & Selenium *pounds
Mol文件: 583-39-1.mol
雷貝拉唑中間體
©2025 武漢康寶泰精細化工有限公司武昌一部 版權所有   技術支持:化工網   訪問量:16912  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |